1. Home
  2. FORTY vs NKTR Comparison

FORTY vs NKTR Comparison

Compare FORTY & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$106.50

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$63.65

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORTY
NKTR
Founded
1985
1990
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.1B
IPO Year
1998
1996

Fundamental Metrics

Financial Performance
Metric
FORTY
NKTR
Price
$106.50
$63.65
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$146.67
AVG Volume (30 Days)
414.0
901.8K
Earning Date
05-21-2026
05-07-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.65
N/A
Revenue Growth
N/A
86.00
52 Week Low
$106.50
$21.02
52 Week High
$190.56
$109.00

Technical Indicators

Market Signals
Indicator
FORTY
NKTR
Relative Strength Index (RSI) 33.61 44.72
Support Level $101.21 $53.27
Resistance Level $136.43 $66.52
Average True Range (ATR) 1.43 3.10
MACD -2.88 1.12
Stochastic Oscillator 0.00 59.00

Price Performance

Historical Comparison
FORTY
NKTR

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.

Share on Social Networks: